北ヨーロッパの薬事申請市場2021-2028:サービス別、サービスプロバイダ別、企業規模別、カテゴリー別、製品別、疾患別、エンドユーザー別、国別

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV21MH018)
◆英語タイトル:Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028
◆発行会社/調査会社:Grand View Research
◆商品コード:GV21MH018
◆発行日:2021年3月12日
◆調査対象地域:北ヨーロッパ
◆産業分野:医療
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[北ヨーロッパの薬事申請市場2021-2028:サービス別、サービスプロバイダ別、企業規模別、カテゴリー別、製品別、疾患別、エンドユーザー別、国別]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、北ヨーロッパの薬事申請市場規模が2028年までに272.7百万ドルに達すると予測しています。2021年から2028年までに年平均7.5%成長する見通しです。本調査資料では、薬事申請の北ヨーロッパ市場を広く調査・分析し、手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、サービス別分析、サービスプロバイダ別分析、企業規模別分析、カテゴリー別分析、国別分析、競争状況など、以下の構成でまとめております。
*** レポート概要(サマリー)***

Nordic Regulatory Affairs Market Growth & Trends
The Nordic regulatory affairs market size is expected to reach USD 272.7 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.5% from 2021 to 2028. An increase in R&D activities in countries such as Denmark and Norway, drug pipeline, and clinical trial applications are some of the key factors expected to drive the market.

Denmark is the hub of R&D activities in Europe. The country is known for its long tradition for collaborative R&D and the fastest approval of clinical trials makes it a preferred destination to perform drug discovery and development. Denmark also has the largest commercial drug-development pipeline in Europe. Thus, the urge for a faster drug approval process is one of the key factors expected to drive the market in the country.

In Sweden, as stated by the SwedenBIO, around 148 companies have 420 drug development projects; an increase by 51 projects compared to 2016. In addition, around 6% of the total exports from Sweden are related to pharmaceuticals. Hence, this is projected to create demand for regulatory affairs services in the country.

The ongoing COVID-19 pandemic is expected to create the need for regulatory affairs in the Nordic countries. Countries such as Sweden and Denmark, which are the hub of clinical trials, are expected to witness an increase in demand for regulatory services as many of the trials are put on hold. In addition to this, due to COVID-19, a significant number of vaccines and drugs are in the development stage, which requires faster approval. This is possible only through clearance by regulatory bodies. Thus, the need for regulatory affairs is expected to increase in the Nordic countries.

Nordic Regulatory Affairs Market Report Highlights

• By service, the regulatory writing and publishing segment led the market in 2020 owing to an increase in the outsourcing of selected regulatory functions by major life sciences companies

• Based on category, the medical devices segment held the largest share in 2020. The segment is driven by stiff competition owing to the increased demand for wearable devices

• Sweden dominated the market with a share of 59.6% in 2020 due to a rise in the number of drug development projects

• Changing regulatory landscape, increasing need for companies to focus on core business activities, and economic and competitive pressures are the main factors responsible for the market growth

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Service Provider
1.1.3. Company Size
1.1.4. Category
1.1.5. Product Stage
1.1.6. Indication
1.1.7. End Use
1.1.8. Country Scope
1.1.9. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the given 5 Nordic countries
1.9.2. Understanding market estimates and forecasts
1.9.3. Understanding attributes such as strategy framework and competitor categorization
1.9.4. Understanding the key service and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Nordic Regulatory Affairs Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Industry challenges
3.3. Nordic Regulatory Affairs Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Major Deals & Strategic Alliances Analysis
3.3.4. Market Entry Strategies
Chapter 4. Nordic Regulatory Affairs Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
4.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.3.1. Regulatory consulting
4.3.2. Legal representation
4.3.3. Regulatory writing & publishing
4.3.4. Product registration & clinical trial applications
4.3.5. Other services
Chapter 5. Nordic Regulatory Affairs Market: Service Provider Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
5.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.3.1. In-house
5.3.2. Outsourcing
Chapter 6. Nordic Regulatory Affairs Market: Company Size Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
6.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.3.1. Small
6.3.2. Medium
6.3.3. Large
Chapter 7. Nordic Regulatory Affairs Market: Category Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
7.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
7.3.1. Drugs
7.3.2. Biologics
7.3.3. Medical Devices
Chapter 8. Nordic Regulatory Affairs Market: Product Stage Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
8.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
8.3.1. Preclinical
8.3.2. Clinical Studies
8.3.3. PMA
Chapter 9. Nordic Regulatory Affairs Market: Indication Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
9.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
9.3.1. Oncology
9.3.2. Neurology
9.3.3. Cardiology
9.3.4. Immunology
9.3.5. Others
Chapter 10. Nordic Regulatory Affairs Market: End-use Estimates & Trend Analysis
10.1. Segment Dashboard
10.2. Nordic Regulatory Affairs Market Share, 2020 & 2028
10.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
10.3.1. Medical Device Companies
10.3.2. Pharmaceutical Companies
10.3.3. Biotechnology Companies
Chapter 11. Nordic Regulatory Affairs Market: Country Estimates & Trend Analysis
11.1. Country Market Dashboard
11.2. Country Market Share Analysis, 2020 & 2028
11.3. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
11.3.1. Sweden
11.3.2. Norway
11.3.3. Denmark
11.3.4. Finland
11.3.5. Iceland
Chapter 12. Competitive Landscape
12.1. Recent Developments & Impact Analysis, By Key Market Participants
12.1.1. Pharma Assist Sweden AB
12.1.1.1. Company overview
12.1.1.2. Financial performance
12.1.1.3. Product benchmarking
12.1.1.4. Strategic initiatives
12.1.2. GenPact Ltd.
12.1.2.1. Company overview
12.1.2.2. Financial performance
12.1.2.3. Product benchmarking
12.1.2.4. Strategic initiatives
12.1.3. PRA Health Sciences
12.1.3.1. Company overview
12.1.3.2. Financial performance
12.1.3.3. Product benchmarking
12.1.3.4. Strategic initiatives
12.1.4. Charles River Laboratories International Inc.
12.1.4.1. Company overview
12.1.4.2. Financial performance
12.1.4.3. Product benchmarking
12.1.4.4. Strategic initiatives
12.1.5. ICON plc
12.1.5.1. Company overview
12.1.5.2. Financial performance
12.1.5.3. Product benchmarking
12.1.5.4. Strategic initiatives
12.1.6. Parexel International Corporation, Inc.
12.1.6.1. Company overview
12.1.6.2. Financial performance
12.1.6.3. Product benchmarking
12.1.6.4. Strategic initiatives
12.1.7. Freyr
12.1.7.1. Company overview
12.1.7.2. Financial performance
12.1.7.3. Product benchmarking
12.1.7.4. Strategic initiatives
12.1.8. Global Pharma Consultancy AB
12.1.8.1. Company overview
12.1.8.2. Financial performance
12.1.8.3. Product benchmarking
12.1.8.4. Strategic initiatives
12.1.9. Accell Clinical Research LLC
12.1.9.1. Company overview
12.1.9.2. Financial performance
12.1.9.3. Product benchmarking
12.1.9.4. Strategic initiatives
12.1.10. Regsmart Lifesciences AB
12.1.10.1. Company overview
12.1.10.2. Financial performance
12.1.10.3. Product benchmarking
12.1.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Nordic Regulatory Affairs Market, By Countries, 2016 - 2028 (USD Million)
Table 4 Nordic Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 5 Nordic Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 6 Nordic Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 7 Nordic Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 8 Nordic Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 9 Nordic Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 10 Nordic Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 11 Nordic Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 12 Nordic Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 13 Nordic Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 14 Nordic Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 15 Nordic Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 16 Nordic Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 17 Nordic Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 18 Nordic Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 19 Nordic Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 20 Nordic Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)
Table 21 Sweden Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 22 Sweden Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 23 Sweden Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 24 Sweden Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 25 Sweden Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 26 Sweden Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 27 Sweden Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 28 Sweden Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 29 Sweden Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 30 Sweden Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 31 Sweden Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 32 Sweden Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 33 Sweden Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 34 Sweden Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 35 Sweden Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 36 Sweden Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 37 Sweden Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)
Table 38 Norway Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 39 Norway Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 40 Norway Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 41 Norway Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 42 Norway Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 43 Norway Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 44 Norway Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 45 Norway Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 46 Norway Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 47 Norway Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 48 Norway Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 49 Norway Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 50 Norway Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 51 Norway Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 52 Norway Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 53 Norway Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 54 Norway Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)
Table 55 Denmark Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 56 Denmark Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 57 Denmark Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 58 Denmark Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 59 Denmark Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 60 Denmark Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 61 Denmark Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 62 Denmark Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 63 Denmark Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 64 Denmark Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 65 Denmark Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 66 Denmark Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 67 Denmark Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 68 Denmark Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 69 Denmark Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 70 Denmark Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 71 Denmark Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)
Table 72 Finland Regulatory Affairs Market, By Countries, 2016 - 2028 (USD Million)
Table 73 Finland Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 74 Finland Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 75 Finland Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 76 Finland Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 77 Finland Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 78 Finland Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 79 Finland Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 80 Finland Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 81 Finland Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 82 Finland Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 83 Finland Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 84 Finland Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 85 Finland Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 86 Finland Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 87 Finland Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 88 Finland Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 89 Finland Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)
Table 90 Iceland Regulatory Affairs Market, By Service, 2016 - 2028 (USD Million)
Table 91 Iceland Regulatory Affairs Market, By Service provider, 2016 - 2028 (USD Million)
Table 92 Iceland Regulatory Affairs Market, By Company size, 2016 - 2028 (USD Million)
Table 93 Iceland Regulatory Affairs Market, By Category, 2016 - 2028 (USD Million)
Table 94 Iceland Regulatory Affairs Market, By Drugs, 2016 - 2028 (USD Million)
Table 95 Iceland Regulatory Affairs Market, By Innovator, 2016 - 2028 (USD Million)
Table 96 Iceland Regulatory Affairs Market, By Generics, 2016 - 2028 (USD Million)
Table 97 Iceland Regulatory Affairs Market, By Biologics, 2016 - 2028 (USD Million)
Table 98 Iceland Regulatory Affairs Market, By Biotech, 2016 - 2028 (USD Million)
Table 99 Iceland Regulatory Affairs Market, By ATMP, 2016 - 2028 (USD Million)
Table 100 Iceland Regulatory Affairs Market, By Biosimilar, 2016 - 2028 (USD Million)
Table 101 Iceland Regulatory Affairs Market, By Medical Devices, 2016 - 2028 (USD Million)
Table 102 Iceland Regulatory Affairs Market, By Diagnostics, 2016 - 2028 (USD Million)
Table 103 Iceland Regulatory Affairs Market, By Therapeutics, 2016 - 2028 (USD Million)
Table 104 Iceland Regulatory Affairs Market, By Stage, 2016 - 2028 (USD Million)
Table 105 Iceland Regulatory Affairs Market, By Indication, 2016 - 2028 (USD Million)
Table 106 Iceland Regulatory Affairs Market, By End Use, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Nordic regulatory affairs market snapshot (2020)
Fig. 9 Nordic regulatory affairs market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Personalized medicine as a percentage of CDER approved novel molecules.
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 SWOT
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Nordic regulatory affairs market service outlook: Segment dashboard
Fig. 18 Nordic regulatory affairs market: service movement analysis
Fig. 19 Regulatory consulting market, 2016 - 2028 (USD Million)
Fig. 20 Legal representation market, 2016 - 2028 (USD Million)
Fig. 21 Regulatory writing and publishing market, 2016 - 2028 (USD Million)
Fig. 22 Product registration and clinical trial applications market, 2016 - 2028 (USD Million)
Fig. 23 Other regulatory services market, 2016 - 2028 (USD Million)
Fig. 24 Nordic regulatory affairs market service provider outlook: Segment dashboard
Fig. 25 Nordic regulatory affairs market: Service provider movement analysis
Fig. 26 In-house regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 27 Outsourcing regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 28 Nordic regulatory affairs market company size outlook: Segment dashboard
Fig. 29 Nordic regulatory affairs market: Company Size movement analysis
Fig. 30 Small-sized companies based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 31 Medium-sized companies based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 32 Large-sized companies based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 33 Nordic regulatory affairs market category outlook: Segment dashboard
Fig. 34 Nordic regulatory affairs market: Category movement analysis
Fig. 35 Drugs-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 36 Biologics-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 37 Medical devices-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 38 Nordic regulatory affairs product stage outlook: Segment dashboard
Fig. 39 Nordic regulatory affairs market: Product Stage movement analysis
Fig. 40 Preclinical-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 41 Clinical studies-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 42 PMA-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 43 Nordic regulatory affairs market indication outlook: Segment dashboard
Fig. 44 Nordic regulatory affairs market: indication movement analysis
Fig. 45 Oncology-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 46 Neurology-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 47 Cardiology-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 48 Immunology-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 49 Other indication-based regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 50 Nordic regulatory affairs market end-use outlook: Segment dashboard
Fig. 51 Nordic regulatory affairs market: end-use movement analysis
Fig. 52 Medical device companies market, 2016 - 2028 (USD Million)
Fig. 53 Pharmaceutical companies market, 2016 - 2028 (USD Million)
Fig. 54 Biotechnology companies market, 2016 - 2028 (USD Million)
Fig. 55 Country outlook, 2020 & 2028
Fig. 56 Nordic market, 2016 - 2028 (USD Million)
Fig. 57 Norway market, 2016 - 2028 (USD Million)
Fig. 58 Denmark market, 2016 - 2028 (USD Million)
Fig. 59 Sweden market, 2016 - 2028 (USD Million)
Fig. 60 Iceland market, 2016 - 2028 (USD Million)
Fig. 61 Finland market, 2016 - 2028 (USD Million)
Fig. 62 Organization structure - RegSmart Life Science AB
Fig. 63 SWOT - RegSmart Life Science AB
Fig. 64 Organization structure - Pharm Assist Sweden AB
Fig. 65 SWOT - Pharm Assist Sweden AB
Fig. 66 Organization structure - Genpact
Fig. 67 SWOT - Genpact
Fig. 68 Organization structure - Charles River Laboratories International, Inc.
Fig. 69 SWOT - Charles River Laboratories International, Inc.
Fig. 70 Organization structure - ICON plc
Fig. 71 SWOT - ICON plc
Fig. 72 Organization structure - PAREXEL International Corporation
Fig. 73 SWOT - PAREXEL International Corporation
Fig. 74 Organization structure - Freyr
Fig. 75 SWOT - Freyr
Fig. 76 Organization structure - Accell Clinical Research, LLC
Fig. 77 SWOT - Accell Clinical Research, LLC
Fig. 78 Organization structure - PRA Health Sciences
Fig. 79 SWOT - PRA Health Sciences
Fig. 80 Organization structure - Global Pharma Consulting AB
Fig. 81 SWOT - Global Pharma Consulting AB

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ソリッドステートリレーの世界市場2017-2026
    According to Stratistics MRC, the Global Solid State Relay Market is accounted for $1.07 billion in 2017 and is expected to reach $1.99 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Demand of redesigning ageing intensity of framework in created areas and increase in the found …
  • 海洋支援船舶の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Offshore Support Vessels Revenue, means the sales value of Offshore Support Vessels This report studies sales (consumption) of Offshore Support Vessels in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regio …
  • 世界の医療用保護マスク市場2021-2025
    Medical protective masks usually consists of three layers, used for filtering particles in the air and blocking droplets, blood, body fluids and secretions etc. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Medical P …
  • ショットブラストブースの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Shot-blasting Booths Revenue, means the sales value of Shot-blasting Booths This report studies sales (consumption) of Shot-blasting Booths in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries …
  • 封止樹脂の世界市場
    In this report, the global Encapsulation Resins market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, reve …
  • 小売の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測
    The retail industry has witnessed several changes during the study period with changing economic conditions across the world. The global economy, which slowed in 2019, has crashed in 2020 due to the COVID-19 outbreak resulting in a challenging forecast period for the retail industry. As the majority …
  • 状態監視装置の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測
    The condition monitoring equipment market is valued at USD 1.99 billion in 2020 and expected to grow at a CAGR of over 5.59% during the forecast period 2021 - 2026 to reach a value of USD 2.61 billion in 2026. The condition Monitoring system is a predictive maintenance system providing real-time dat …
  • 乾燥剤の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Drying Agents Revenue, means the sales value of Drying Agents This report studies sales (consumption) of Drying Agents in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, …
  • 2,4,5-トリクロロフェノールの世界市場2021
    The Global 2,4,5-Trichlorophenol (CAS 95-95-4) Industry 2021 Market Research Report is a professional and in-depth study on the current state of the 2,4,5-Trichlorophenol industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and …
  • コロンビアの建設市場(~2019)
    Timetric’s Construction in Colombia – Key Trends and Opportunities to 2019 report provides detailed market analysis, information and insights into the Colombian construction industry including: • The Colombian construction industry's growth prospects by market, project type and type of construction …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV21MH018 )"北ヨーロッパの薬事申請市場2021-2028:サービス別、サービスプロバイダ別、企業規模別、カテゴリー別、製品別、疾患別、エンドユーザー別、国別" (英文:Nordic Regulatory Affairs Market Size, Share & Trends Analysis Report By Service, By Service Provider, By Company Size, By Category, By Product Stage, By Indication, By End-use, By Country, And Segment Forecasts, 2021 - 2028)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。